We are live on ! Find out more
CEMP

Cempra, Inc.
CEMP

Delisted

CEMP was delisted on the 3rd of November, 2017.

130 hedge funds and large institutions have $81.7M invested in Cempra, Inc. in 2016 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 33 increasing their positions, 36 reducing their positions, and 63 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% less call options, than puts

Call options by funds: $3.14M | Put options by funds: $3.26M

8% less repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 36

13% less funds holding

Funds holding: 149130 (-19)

27% less first-time investments, than exits

New positions opened: 46 | Existing positions closed: 63

92% less capital invested

Capital invested by funds: $976M → $81.7M (-$894M)

100% less funds holding in top 10

Funds holding in top 10: 40 (-4)

Holders
130
Holders Change
-19
Holders Change %
-12.75%
% of All Funds
3.25%
Holding in Top 10
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
New
46
Increased
33
Reduced
36
Closed
63
Calls
$3.14M
Puts
$3.26M
Net Calls
-$119K
Net Calls Change
+$7.61M
Name Holding Trade Value Shares
Change
Change in
Stake
MLICM
76
Metropolitan Life Insurance Company (MetLife)
New York
$73K -$56.3K -4,638 -15%
EEG
77
E.E. Geduld
$70K +$303K +25,000 New
First Trust Advisors
78
First Trust Advisors
Illinois
$68K +$295K +24,332 New
BA
79
BlackRock Advisors
Delaware
$67K -$4.9K -404 -2%
AIG
80
American International Group
New York
$67K -$752 -62 -0.3%
PA
81
Perceptive Advisors
New York
$62K -$1.86M -153,182 -87%
PAWC
82
P.A.W. Capital
Connecticut
$56K +$243K +20,000 New
UBS Group
83
UBS Group
Switzerland
$55K -$963K -79,440 -80%
State Board of Administration of Florida Retirement System
84
State Board of Administration of Florida Retirement System
Florida
$53K +$2.43K +200 +1%
BG
85
BlackRock Group
United Kingdom
$53K +$27.7K +2,287 +14%
Legal & General Group
86
Legal & General Group
United Kingdom
$53K +$113K +9,292 +95%
Janney Montgomery Scott
87
Janney Montgomery Scott
Pennsylvania
$51K +$1.82K +150 +0.8%
WS
88
Wedbush Securities
California
$50K +$218K +18,000 New
VOYA Investment Management
89
VOYA Investment Management
Georgia
$48K -$7.83M -645,207 -97%
Jane Street
90
Jane Street
New York
$46K +$201K +16,543 New
Two Sigma Advisers
91
Two Sigma Advisers
New York
$41K +$178K +14,700 New
Russell Investments Group
92
Russell Investments Group
United Kingdom
$38K +$177K +14,633 New
CIC
93
Chase Investment Counsel
Virginia
$37K +$164K +13,500 New
Public Employees Retirement Association of Colorado
94
Public Employees Retirement Association of Colorado
Colorado
$35K
RJA
95
Raymond James & Associates
Florida
$34K -$471K -38,850 -76%
Bank of America
96
Bank of America
North Carolina
$33K -$106K -8,727 -43%
JRP
97
Jasper Ridge Partners
California
$33K
ID
98
Integral Derivatives
New York
$33K +$141K +11,653 New
CIM
99
CIM Investment Management
Pennsylvania
$31K
T. Rowe Price Associates
100
T. Rowe Price Associates
Maryland
$30K -$705K -58,116 -84%

CEMP Hedge Fund Activity: Q4 2016 in Review

130 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Cempra, Inc. (CEMP) for Q4 2016, worth a combined $81.7M — down 92% from $976M a quarter earlier.

Sellers outnumbered buyers: 63 funds closed out of CEMP and 46 opened new positions — a net loss of 17 holders — while 36 trimmed existing stakes and 33 added.

The largest buyer was Deutsche Bank, adding an estimated $13M. The largest seller was BB Biotech, exiting entirely with an estimated $49.4M sold.

  • 130 institutional investors held Cempra, Inc. (CEMP) as of Q4 2016, down from 149 in Q3 2016.
  • Funds reported $81.7M of Cempra, Inc. stock for Q4 2016, down 92% quarter-over-quarter.
  • 46 funds opened new Cempra, Inc. positions in Q4 2016 and 63 closed out, a net change of -17 holders.
  • The largest Cempra, Inc. buyer in Q4 2016 was Deutsche Bank, an estimated $13M added.
  • The largest Cempra, Inc. seller in Q4 2016 was BB Biotech, an estimated $49.4M sold.

Based on aggregated 13F filings for Q4 2016.